SG Americas Securities LLC raised its holdings in shares of Doximity, Inc. (NYSE:DOCS – Free Report) by 3,403.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,408,597 shares of the company’s stock after buying an additional 1,368,388 shares during the quarter. SG Americas Securities LLC’s holdings in Doximity were worth $32,820,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. grew its stake in shares of Doximity by 99.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after acquiring an additional 397 shares during the last quarter. Toth Financial Advisory Corp raised its stake in Doximity by 100.0% during the 4th quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock valued at $44,000 after purchasing an additional 500 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Doximity by 35.7% during the 4th quarter. Farther Finance Advisors LLC now owns 1,539 shares of the company’s stock valued at $68,000 after purchasing an additional 405 shares during the last quarter. Leonteq Securities AG bought a new stake in Doximity in the 4th quarter valued at $78,000. Finally, Kestra Advisory Services LLC bought a new stake in Doximity in the 4th quarter valued at $87,000. 87.19% of the stock is owned by institutional investors.
Insider Activity
In other Doximity news, Director Kira Scherer Wampler sold 9,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total value of $234,540.00. Following the transaction, the director directly owned 19,839 shares in the company, valued at $517,004.34. The trade was a 31.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,444 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the sale, the insider directly owned 90,706 shares of the company’s stock, valued at approximately $1,851,309.46. The trade was a 2.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 16,180 shares of company stock valued at $395,110 over the last three months. 31.30% of the stock is currently owned by insiders.
Doximity Trading Up 2.4%
Analyst Upgrades and Downgrades
DOCS has been the topic of several research reports. Canaccord Genuity Group dropped their price objective on shares of Doximity from $34.00 to $30.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Robert W. Baird reiterated a “neutral” rating and issued a $18.00 target price (down from $40.00) on shares of Doximity in a research note on Thursday, May 14th. BMO Capital Markets decreased their target price on Doximity from $25.00 to $20.00 and set a “market perform” rating on the stock in a research report on Thursday, May 14th. The Goldman Sachs Group lowered their price target on Doximity from $28.00 to $24.00 and set a “neutral” rating on the stock in a research note on Thursday, May 14th. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $18.00 price target (down from $32.00) on shares of Doximity in a report on Thursday, May 14th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Doximity has a consensus rating of “Hold” and a consensus price target of $30.62.
View Our Latest Analysis on DOCS
Doximity Profile
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Read More
- Five stocks we like better than Doximity
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NYSE:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
